Cited by 40RNA Research and SplicingGenomics and Chromatin DynamicsAdrenal Hormones and Disorders

Alternate promoters and alternate splicing of human Tenascin-X, a gene with 5′ and 3′ ends buried in other genes

Speek, M·1996·Human Molecular Genetics

Abstract

Tenascin-X (TN-X) is an extracellular matrix protein encoded by a large gene that overlaps the steroid 21-hydroxylase (P450c21) gene in the HLA locus on chromosome 6p21.3. This may be the most complex locus in the human genome identified to date, containing 13 overlapping transcription units in 160 kb of DNA. Previous studies determined the sequence of 39 TN-X exons, encoding a 12 kb open reading frame, but the promoter(s) of the gene had not been located. We identify the principal TN-X promoter and a previously unknown 5' untranslated exon that lies more than 10 kb upstream from the previously known exons. This promoter, which is substantially different from the promoter for TN-C, initiates transcription in human fetal adrenal and muscle, but expression in human NCI-H295 adrenocortical carcinoma cells is initiated by two other promoters lying further upstream. One of these is the same as the promoter for a recently identified Creb-related protein (Creb-rp), but transcripts initiated form this promoter in human adrenal NCI-H295 tumor cells are spliced differently from Creb-rp, and are largely retained in the nuclei of these cells. By analogy with the other two members of the tenascin family, TN-C and TN-R, it has been predicted that TN-X should undergo alternate splicing in its fibronectin-like domains. RACE cloning and RNase protection experiments reveal no such alternate splicing. The TN-X gene appears to be unique in having both its 5' and 3' ends buried in other genes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/hmg/5.11.1749

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The XB gene spans about 65 kb of DNA and includes 43 exons encoding a 12 kb mRNA.

    “The XB gene spans about 65 kb of DNA and includes 43 exons encoding a 12 kb mRNA (399, 401).”

    From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [401]

    The ‘Size of the human TN-X transcript’ section reports an approximately 12 kb mRNA, supporting that part of the claim. The Introduction says XB is over 65 kb long, while the Discussion estimates the gene at about 100 kb; the copy does not establish the claimed 43 exons (page numbers unavailable). (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Carroll, M.C., Campbell, R.D. and Porter, R.R. (1985) Mapping of steroid 21-hydroxylase genes to complement component C4 genes in HLA, the major histocompatibility locus in man. Proc. Natl Acad. Sci. USA 82, 521-525.
  2. Pearson, W.R. (1990) In R. F. Doolittle (ed.), Methods in Enzymology, Rapid and sensitive sequence comparison with FASTP and FASTA. Academic Press, Inc., 183, 63-98.

Cited by

Sorted by citations

Authors
Speek, M.
Affiliations
University of California, San Francisco (US)
Corresponding author
Speek, M
Venue
Human Molecular Genetics
Published
1996-11-01
Volume
5
Issue
11
Pages
1749-1758
ISSN
  • 0964-6906 (ISSN-L)
  • 1460-2083
OpenAlex
W2114370038
Cited by
40
References
52
Citations by year
2021: 4 · 2020: 2 · 2018: 2 · 2015: 1 · 2013: 1
FWCI
1.14
Type
journal article
Language
en
Open access
closed
Locations
  • Human Molecular Genetics (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • March of Dimes Foundation
  • National Institutes of Health
  • National Cancer Institute
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK-37922, R01DK037922)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Keywords
tenascin-X, alternative splicing, P450c21, HLA locus, chromosome 6p21.3, extracellular matrix proteins, NCI-H295 cells, gene structure
MeSH terms
Adrenal Glands, Amino Acid Sequence, Base Sequence, Choriocarcinoma, Exons, Genes, Overlapping, Humans, Molecular Sequence Data, Promoter Regions, Genetic, RNA, Messenger, Transcription, Genetic, Tumor Cells, Cultured, Cyclic AMP Response Element-Binding Protein, Alternative Splicing, Adrenocortical Carcinoma, Muscle, Skeletal, Tenascin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review